Quote:
Originally Posted by Marcellus
Yea I addressed it 2 weeks ago, you are using 1 city which is a major outlier and using 100% incomplete data on flu numbers so you still didn't prove me wrong.
|
100% incomplete data? It's data from the 2017-8 flu season, which has been over for two years.
I'm using one city, which has a sample size of 8,000,000 people to draw from. Their serology data does not point to a substantively higher IFR than other regions given the cumulative number of infections, nor is at an outlier.
Serology study from Spain points to 5% prevalence with an IFR of 1.1%
New York City serology information points to 21% prevalence with an IFR of 0.977%
There's nothing different about New York's epidemic from Spain's if you look at IFR--it's not an outlier. Given that, we can draw pretty clear comparisons to age-related mortality, which is, again, substantially higher for every cohort over 18, than the flu.